Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYH2082 in Healthy Participants
NCT07736404Phase 1Active, not recruiting
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity comparing SYH2082 Injection Experimental with Placebo Comparator (2 arms). Primary endpoint: Number of participants with treatment-related adverse events at Day 57. Started Apr 2026; status: active, not recruiting.
02
Drugs
SYH2082
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07736404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07736404.